Clinical Briefing Report

Adobe Stock
Lori Solomon
1 min read
No meaningful population-level survival improvement seen from 1990 to 2023
Adobe
Elana Gotkine
2 min read
Median DFS was not reached in group receiving aglatimagene plus valacyclovir followed by EBRT after median follow-up of 50.3 months
Read More
Clinical Briefing Report
clinicalbriefingreport.com